Puri Michal Nath bought NVCR
February 27, 2024 · Form 4 insider transaction
Puri Michal Nath bought 71,574 shares of NovoCure Limited at $16.30 per share, a transaction worth $1.17M. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
71,574
Price
$16.30
Total value
$1.17M
InsiderPuri Michal Nath
RoleOfficer
CompanyNovoCure Limited (NVCR)
SecurityOrdinary Shares
Transaction codeA: Grant or award
Transaction dateFebruary 27, 2024
Filing dateFebruary 29, 2024
Shares owned after109,167
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents restricted share units that are scheduled to vest in equal installments on February 27, 2025, 2026 and 2027, subject to the reporting person's continued employment through such dates.